CIP
WST icon

Chartwell Investment Partners’s West Pharmaceutical WST Stock Holding History

Chartwell Investment Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$870K Sell
2,899
-11,080
-79% -$3.39M 0.03% 363
2024
Q2 		$4.61M Buy
13,979
+9,928
+245% +$3.51M 0.16% 190
2024
Q1 		$1.6M Buy
+4,051
New +$1.5M 0.06% 311
2015
Q3 		– Sell
-309,800
Closed -$18M – 320
2015
Q2 		$18M Buy
309,800
+1,547
+0.5% +$86.3K 0.35% 97
2015
Q1 		$18.6M Buy
308,253
+4,303
+1% +$229K 0.36% 106
2014
Q4 		$16.2M Sell
303,950
-2,950
-1% -$148K 0.34% 110
2014
Q3 		$13.7M Buy
+306,900
New +$13M 0.31% 127

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chartwell Investment Partners's WST Position: Q3 2024 in Review

Chartwell Investment Partners reduced its West Pharmaceutical (WST) stake by 79% in Q3 2024, selling an estimated $3.39M and leaving 2,899 shares worth $870K. The position accounts for 0.03% of the portfolio, ranked #363.

Chartwell Investment Partners first reported a position in WST in Q3 2014 and has held it in 7 quarters since. The position peaked at $18.6M in Q1 2015. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Chartwell Investment Partners held 2,899 shares of West Pharmaceutical worth $870K as of Q3 2024.
  • Chartwell Investment Partners sold 11,080 West Pharmaceutical shares in Q3 2024, an estimated $3.39M.
  • West Pharmaceutical made up 0.03% of Chartwell Investment Partners's portfolio in Q3 2024, its #363 holding.
  • Chartwell Investment Partners first reported a position in West Pharmaceutical in Q3 2014 and has held it in 7 quarters since.
  • Chartwell Investment Partners's West Pharmaceutical position peaked at $18.6M in Q1 2015.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.